Developing multi-target therapeutics to fine-tune the evolutionary dynamics of the cancer ecosystem
Authors:
Open Access
- 24 September 2015
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 6, 209
Abstract
Developing multi-target therapeutics to fine-tune the evolutionary dynamics of the cancer ecosystemKeywords
Funding Information
- National Institutes of Health (R01-LM011986)
This publication has 39 references indexed in Scilit:
- Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunityNature, 2015
- Patient-derived models of acquired resistance can identify effective drug combinations for cancerScience, 2014
- Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modelingClinical & Experimental Metastasis, 2014
- Constraint-based models predict metabolic and associated cellular functionsNature Reviews Genetics, 2014
- Cell-Cell Communication in the Tumor Microenvironment, Carcinogenesis, and Anticancer TreatmentCellular Physiology and Biochemistry, 2014
- Evolutionary dynamics of cancer in response to targeted combination therapyeLife, 2013
- Hallmarks of cancer: of all cancer cells, all the time?Trends in Molecular Medicine, 2012
- Agent‐based models in translational systems biologyWIREs Mechanisms of Disease, 2009
- Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinasesNature Chemical Biology, 2008
- The Problem of Cancer Dormancy: Understanding the Basic Mechanisms and Identifying Therapeutic OpportunitiesCell Cycle, 2006